The Patent Finder

J-Pharma Co., Ltd.

2 patents currently held · Updated Nov 21, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 2 of 2

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,173,990URAT1 Inhibitor
In force
 · High confidence
In forceHigh confidence
US 12,458,628Cancer therapeutic
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 2: 1 patent in force now held by others · 7 lapsed for an unpaid fee · 9 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 3 abandoned · 6 no status recorded

Showing 1 to 10 of 11, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/771,230Method of Treating Biliary Tract CancerJul 12, 2024Pending
17/169,033Feb 5, 2021No status recorded
17/638,680A Pharmaceutical Composition Used for a Patient Having Specific Genetic MarkerAug 31, 2020Abandoned
17/638,669A Pharmaceutical Composition for Treating Cancer Used for a Patient Having Specific Genetic MarkerAug 31, 2020Pending
16/328,214Mar 10, 2016No status recorded
14/899,572Blood-Based Biomarker for CancerJun 9, 2015Abandoned
13/325,574Dec 14, 2011No status recorded
12/658,612Feb 8, 2010No status recorded
12/228,769Aug 15, 2008Abandoned
12/526,062Feb 6, 2007No status recorded
10 of 11 applications shown.
Pro members see all 11 published applications.
Pro members: see all 11 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited